Evaluation of NADPH oxidases as drug targets in a mouse model of familial amyotrophic lateral sclerosis.
about
Pharmacological Modulation of Functional Phenotypes of Microglia in Neurodegenerative DiseasesDecreased neural precursor cell pool in NADPH oxidase 2-deficiency: From mouse brain to neural differentiation of patient derived iPSC.European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS).Decreased NOX2 expression in the brain of patients with bipolar disorder: association with valproic acid prescription and substance abuse.Detection and Characterization of Reactive Oxygen and Nitrogen Species in Biological Systems by Monitoring Species-Specific Products.
P2860
Evaluation of NADPH oxidases as drug targets in a mouse model of familial amyotrophic lateral sclerosis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Evaluation of NADPH oxidases a ...... amyotrophic lateral sclerosis.
@en
Evaluation of NADPH oxidases a ...... amyotrophic lateral sclerosis.
@nl
type
label
Evaluation of NADPH oxidases a ...... amyotrophic lateral sclerosis.
@en
Evaluation of NADPH oxidases a ...... amyotrophic lateral sclerosis.
@nl
prefLabel
Evaluation of NADPH oxidases a ...... amyotrophic lateral sclerosis.
@en
Evaluation of NADPH oxidases a ...... amyotrophic lateral sclerosis.
@nl
P2093
P50
P1476
Evaluation of NADPH oxidases a ...... amyotrophic lateral sclerosis
@en
P2093
Adriano Aguzzi
Aleksandra Filippova
Elisabeth J Rushing
Ghassan J Maghzal
Maria T Giordana
Olivier Basset
Olivier Plastre
Roland Stocker
Shuo-Chien Ling
Tamara Seredenina
P304
P356
10.1016/J.FREERADBIOMED.2016.05.016
P577
2016-05-19T00:00:00Z